The vision research program at the University of Oklahoma Health Sciences Center and Dean McGee Eye Institute recently received a five-year, $2.9 million grant renewal from the National Eye...

As COVID-19 has demonstrated, viruses can emerge at any time and wreak havoc across the globe. Because many viruses mutate quickly, there are very few drugs to treat them, nor are there vaccines...

Patients 80 and older who are treated with single-agent immunotherapies for some cancers benefit from these innovative treatments and have somewhat comparable outcomes to younger people who...

OU College of Medicine researcher Jody Summers, Ph.D., recently discovered one of the body’s regulators of inflammation, a protein called Interleukin-6 (IL-6), plays a role in the...